Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

CUL4A overexpression

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

CUL4A overexpression	Sarcoma	CUL4A overexpression	Sarcoma	doxorubicin hydrochloride + trabectedin Sensitive: C3 – Early Trials doxorubicin hydrochloride + trabectedin Sensitive : C3	doxorubicin hydrochloride + trabectedin Sensitive: C3 – Early Trials doxorubicin hydrochloride + trabectedin Sensitive : C3
CUL4A overexpression	Soft Tissue Sarcoma	CUL4A overexpression	Soft Tissue Sarcoma	trabectedin Sensitive: C3 – Early Trials trabectedin Sensitive : C3	trabectedin Sensitive: C3 – Early Trials trabectedin Sensitive : C3
CUL4A overexpression	Multiple Myeloma	CUL4A overexpression	Multiple Myeloma	thalidomide Sensitive: C3 – Early Trials thalidomide Sensitive : C3	thalidomide Sensitive: C3 – Early Trials thalidomide Sensitive : C3
CUL4A overexpression	Multiple Myeloma	CUL4A overexpression	Multiple Myeloma	lenalidomide Sensitive: C3 – Early Trials lenalidomide Sensitive : C3	lenalidomide Sensitive: C3 – Early Trials lenalidomide Sensitive : C3